A pilot study of oral calcitriol (1,25-dihydroxyvitamin D(sub 3)) for relapsing - remitting multiple sclerosis

Authors :: Wingerchuk, D.M.
Lesaux, J.
Rice, G.P.A.
Kremenchutzky, M.
Ebers, G.C.
Source :: Journal of Neurology, Neurosurgery and Psychiatry. Sept, 2005, Vol. 76 Issue 9, p1294, 3 p.
Publication Year :: 2005

Subjects :: Multiple sclerosis -- Drug therapy
Multiple sclerosis -- Prevention
Calcitriol -- Dosage and administration
Health
Psychology and mental health

Tools